Clinical Trials Arena April 22, 2022
We’ve analysed companies’ annual reports and other filings to see which key issues are receiving the most attention.
Mentions of robotics within the filings of companies in the pharmaceutical industry rose 25% between the third and fourth quarters of 2021.
In total, the frequency of sentences related to robotics during 2021 was 20% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.
When pharmaceutical companies publish annual and quarterly reports, ESG reports and other filings, GlobalData analyses the text and identifies individual sentences that relate to disruptive forces facing companies in the coming years. Robotics...
Today's Sponsors
Today's Sponsor